Pursuant to Regulation 30 and Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith a copy of transcript of Conference Call held on Tuesday, June 02, 2026.
Pursuant to Regulation 30 and Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Audio recording of Conference Call held on Tuesday, June 02, 2026, is available on the website of the Company.
This has reference to our intimation under regulation 30(9) of SEBI (LODR) Regulation, 2015 submitted to the Stock Exchange on May 27, 2026, regarding the outcome of the Board Meeting of Material Unlisted Subsidiary (i.e. Natural Biogenex Private Limited) dealing the approval of the Right Issue. We wish to inform the exchange that due to a Typographical /Clerical error, the total number of Equity Shares for the right issue was in inadvertently mentioned as 11,11,200 instead of 11,11,205.
Due to the Technical error in the previously published link for the Conference Call with the Investors/Analysts on the Stock Exchange, we are publishing the corrected link for the upcoming Conference Call, i.e. Tuesday, June 02, 2026.
We hereby inform that the audited financial results for the quarter and year ended March 31, 2026 has been published in Business Line, an english daily and Sanjevani, a Kannada daily.
Pursuant to Regulation 30 of SEBI (LODR) Reg. 2015, find enclosed herewith the copy of investor presentation in connection with the Audited Standalone & Consolidation Financial Results for quarter & year ended March 31, 2026.
Pursuant to Reg. 30 of SEBI (LODR) Reg 2015, Find enclosed herewith the copy of press release made to analysts and investors in connection with Audited Standalone & Consolidated Financial Results for quarter & year ended March 31, 2026.
We would like to inform you that the Company shall hold Conference Call with Investors on Tuesday, June 02, 2026 at 04:00 PM IST to discuss the Audited Financial Results for the Fourth Quarter and Year ended March 31, 2026 of the Company and discuss Business Outlook.
Pursuant to Regulation 24A of SEBI (LODR) Regulations, 2015. Please find enclosed the Annual Secretarial Compliance Report dated May 27, 2026 for the FY ended March 31, 2026 issued by Mr. R. Parthasarathy, Practicing Company Secretary.
Appointment of Mr. Akshay Dutta (M.No. A80481) as Company Secretary and Compliance Officer of the Company w.e.f. May 27, 2026.
| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | 37.70 | 37.52 | 39.98 | 40.22 | 39.18 | 41.22 | 43.83 | 44.97 | 45.20 | 45.80 | 37.75 | 58.45 |
| YOY Revenue Growth % | -14.69% | -16.73% | -12.13% | 6.91% | 3.93% | 9.87% | 9.62% | 11.81% | 15.37% | 11.11% | -13.88% | 29.98% |
| Other Income | 0.17 | 0.35 | 0.50 | 0.92 | 0.18 | 0.11 | 0.11 | 0.30 | 0.36 | 0.16 | 0.45 | 0.76 |
| Total Income | 37.87 | 37.87 | 40.48 | 41.14 | 39.36 | 41.33 | 43.94 | 45.27 | 45.56 | 45.96 | 38.19 | 59.22 |
| Total Expenses + | 35.18 | 35.73 | 38.68 | 39.71 | 38.59 | 40.71 | 43.43 | 44.38 | 51.63 | 53.66 | 47.28 | 64.29 |
| Cost of Materials Consumed | 19.79 | 20.40 | 21.26 | 22.55 | 20.38 | 21.24 | 22.31 | 22.95 | 23.58 | 24.84 | 25.34 | 29.47 |
| Employee Benefit Expense | 2.87 | 2.89 | 3.10 | 3.52 | 3.31 | 3.29 | 3.82 | 3.71 | 5.38 | 5.55 | 5.73 | 5.48 |
| Other Expenses | 10.89 | 10.85 | 10.87 | 11.85 | 11.53 | 13.60 | 13.46 | 14.07 | 15.93 | 16.82 | 15.37 | 16.16 |
| Operating Profit | 2.52 | 1.79 | 1.30 | 0.51 | 0.59 | 0.51 | 0.39 | 0.59 | -6.42 | -7.86 | -9.53 | -5.84 |
| OPM % | 6.7% | 4.8% | 3.3% | 1.3% | 1.5% | 1.2% | 0.9% | 1.3% | -14.2% | -17.2% | -25.3% | -10% |
| Profit Before Tax + | 2.69 | 2.14 | 1.80 | 1.43 | 0.77 | 0.62 | 0.50 | 0.89 | -6.06 | -7.69 | -9.08 | -5.08 |
| Tax Expense | 0.87 | 0.58 | 0.59 | 0.46 | 0.17 | 1.23 | 0.40 | 0.37 | -0.48 | -0.71 | -1.97 | -0.10 |
| Tax % | 32.3% | 27.1% | 32.8% | 32.2% | 22.1% | 199.4% | 79% | 41.6% | - | - | - | - |
| Profit After Tax | 1.82 | 1.56 | 1.21 | 0.97 | 0.60 | -0.61 | 0.11 | 0.52 | -5.58 | -6.99 | -7.12 | -4.98 |
| EPS (Basic) | 1.96 | 1.67 | 1.29 | 1.31 | 0.65 | -0.60 | 0.10 | 0.13 | -5.40 | -6.76 | -6.88 | -4.82 |
| Particulars | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
| Revenue from Operations | 187.20 | 169.21 | 155.42 | 172.37 | 135.07 | 79.51 |
| YOY Revenue Growth % | 10.64% | 8.87% | -9.83% | 27.62% | 69.88% | - |
| Other Income | 1.73 | 0.70 | 1.94 | 0.57 | 1.01 | 0.73 |
| Total Income | 188.94 | 169.91 | 157.36 | 172.94 | 136.08 | 80.24 |
| Total Expenses + | 216.86 | 167.12 | 149.31 | 147.95 | 116.69 | 73.26 |
| Cost of Materials Consumed | 103.23 | 86.88 | 84.00 | 83.37 | 56.04 | 36.10 |
| Employee Benefit Expense | 21.00 | 14.13 | 12.37 | 10.73 | 9.62 | 8.05 |
| Other Expenses | 65.41 | 52.65 | 44.47 | 47.92 | 40.27 | 23.10 |
| Operating Profit | -29.65 | 2.09 | 6.11 | 24.42 | 18.38 | 6.25 |
| OPM % | -15.8% | 1.2% | 3.9% | 14.2% | 13.6% | 7.9% |
| Profit Before Exceptional | -27.92 | 2.79 | 8.05 | 24.99 | 19.39 | 6.98 |
| Exceptional Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.18 |
| Profit Before Tax + | -27.92 | 2.79 | 8.05 | 24.99 | 19.39 | 9.16 |
| Tax Expense | -3.26 | 2.17 | 2.50 | 6.55 | 5.47 | 2.25 |
| Tax % | - | 77.9% | 31.1% | 26.2% | 28.2% | 24.6% |
| Profit After Tax | -24.66 | 0.62 | 5.55 | 18.44 | 13.92 | 6.91 |
| EPS (Basic) | -23.84 | 0.22 | 6.23 | 19.82 | 19.56 | 10.99 |
| Particulars | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| Non-Current Assets + | 287.36 | 289.76 | 252.76 | 187.25 | 121.08 | 55.30 |
| Property, Plant & Equipment | 273.33 | 282.33 | 102.24 | 95.39 | 64.26 | 38.11 |
| Capital Work in Progress | 3.70 | 0.00 | 143.81 | 87.70 | 20.11 | 6.98 |
| Non-Current Investments | 2.73 | 2.73 | 2.73 | 0.00 | 0.04 | 0.00 |
| Goodwill | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Intangible Assets | 0.00 | 1.30 | 0.52 | 1.11 | 1.74 | 0.00 |
| Current Assets + | 136.80 | 129.59 | 123.77 | 101.45 | 43.20 | 41.74 |
| Inventories | 26.33 | 25.46 | 19.04 | 8.85 | 4.58 | 6.61 |
| Trade Receivables | 71.35 | 62.24 | 54.47 | 52.13 | 26.30 | 26.70 |
| Cash and Cash Equivalents | 0.22 | 0.69 | 2.25 | 1.48 | 1.40 | 0.10 |
| Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| LIABILITIES & EQUITY | ||||||
| Total Equity | 234.72 | 257.16 | 228.80 | 148.25 | 82.98 | 62.09 |
| Equity Share Capital | 10.39 | 10.34 | 9.33 | 9.28 | 7.01 | 6.23 |
| Other Equity | 211.25 | 222.59 | 194.47 | 113.95 | 75.97 | 55.86 |
| Non-Current Liabilities | 56.71 | 62.20 | 71.25 | 73.57 | 34.85 | 1.08 |
| Current Liabilities | 132.73 | 99.99 | 76.47 | 66.89 | 46.45 | 33.87 |
| Total Liabilities | 189.44 | 162.19 | 147.72 | 140.46 | 81.30 | 34.95 |
| Particulars | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
| Cash from Operating Activities | 10.92 | 26.75 | -8.35 | 15.53 | 1.16 | 12.40 |
| Cash from Investing Activities | -10.77 | -44.48 | -72.59 | -104.63 | -45.88 | -15.57 |
| Cash from Financing Activities | -0.62 | 16.17 | 81.72 | 89.17 | 46.02 | 2.95 |
| Net Increase/Decrease in Cash | -0.47 | -1.57 | 0.78 | 0.08 | 1.30 | -0.22 |